亚洲精品综合日韩中文字幕网站_精品综合久久久久97_中文在线天堂网www_久久精品免费一区二区三区_91久久国产综合精品女同国语_久久资源总站在线国产成人

產(chǎn)品展廳收藏該商鋪

您好 登錄 注冊(cè)

當(dāng)前位置:
美國(guó)布魯克海文儀器公司>技術(shù)文章>ZetaPALS Zeta電位測(cè)量應(yīng)用案例-16

技術(shù)文章

ZetaPALS Zeta電位測(cè)量應(yīng)用案例-16

閱讀:257          發(fā)布時(shí)間:2014-11-13
 文獻(xiàn)名: PLGA Nanoparticle−Peptide Conjugate Effectively Targets Intercellular Cell-Adhesion Molecule-1
 
作者: Na Zhang, Chuda Chittasupho, Chadarat Duangrat, Teruna J. Siahaan and Cory Berkland
Departments of Pharmaceutical Chemistry, and Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047
 
摘要:Targeted delivery of therapeutics possesses the potential to localize therapeutic agents to a specific tissue as a mechanism to enhance treatment efficacy and abrogate side effects. Antibodies have been used clinically as therapeutic agents and are currently being explored for targeting drug-loaded nanoparticles. Peptides such as RGD peptides are also being developed as an inexpensive and stable alternative to antibodies. In this study, cyclo(1,12)PenITDGEATDSGC (cLABL) peptide was used to target nanoparticles to human umbilical cord vascular endothelial cell (HUVEC) monolayers that have upregulated intercellular cell-adhesion molecule-1 (ICAM-1) expression. The cLABL peptide has been previously demonstrated to possess high avidity for ICAM-1 receptors on the cell surface. Poly(dl-lactic-coglycolic acid) nanoparticles conjugated with polyethylene glycol and cLABL demonstrated rapid binding to HUVEC with upregulated ICAM-1, which was induced by treating cells with the proinflammatory cytokine, interferon-γ. Binding of the nanoparticles could be efficiently blocked by preincubating cells with free peptide suggesting that the binding of the nanoparticles is specifically mediated by surface peptide binding to ICAM-1 on HUVEC. The targeted nanoparticles were rapidly endocytosed and trafficked to lysosomes to a greater extent than the untargeted PLGA-PEG nanoparticles. Verification of peptide-mediated nanoparticle targeting to ICAM-1 may ultimay lead to targeting therapeutic agents to inflammatory sites expressing upregulated ICAM-1.

收藏該商鋪

請(qǐng) 登錄 后再收藏

提示

您的留言已提交成功!我們將在第一時(shí)間回復(fù)您~

對(duì)比框

產(chǎn)品對(duì)比 產(chǎn)品對(duì)比 聯(lián)系電話(huà) 二維碼 在線交流

掃一掃訪問(wèn)手機(jī)商鋪
010-62081908
在線留言
拉萨市| 无锡市| 疏附县| 慈利县| 郧西县| 五大连池市| 文山县| 汉阴县| 吴忠市| 阿克苏市| 林州市| 斗六市| 读书| 隆回县| 徐水县| 剑阁县| 探索| 阿克苏市| 巨鹿县| 河曲县| 滦平县| 北海市| 富锦市| 监利县| 本溪| 冕宁县| 华亭县| 南溪县| 清镇市| 和田市| 朔州市| 乐至县| 临清市| 井研县| 通山县| 繁昌县| 黑河市| 洪雅县| 湛江市| 荣昌县| 宜黄县|